These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Knott VJ; Fisher DJ; Millar AM Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194 [TBL] [Abstract][Full Text] [Related]
30. Cross-sensory gating in schizophrenia and autism spectrum disorder: EEG evidence for impaired brain connectivity? Magnée MJ; Oranje B; van Engeland H; Kahn RS; Kemner C Neuropsychologia; 2009 Jun; 47(7):1728-32. PubMed ID: 19397868 [TBL] [Abstract][Full Text] [Related]
31. The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels. Ucar E; Lehtinen EK; Glenthøj BY; Oranje B J Psychopharmacol; 2012 Aug; 26(8):1113-8. PubMed ID: 22331175 [TBL] [Abstract][Full Text] [Related]
32. Probing the relative contribution of the first and second responses to sensory gating indices: a meta-analysis. Chang WP; Arfken CL; Sangal MP; Boutros NN Psychophysiology; 2011 Jul; 48(7):980-92. PubMed ID: 21214588 [TBL] [Abstract][Full Text] [Related]
33. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Quednow BB; Frommann I; Berning J; Kühn KU; Maier W; Wagner M Biol Psychiatry; 2008 Nov; 64(9):766-73. PubMed ID: 18514166 [TBL] [Abstract][Full Text] [Related]
34. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Cadenhead KS; Light GA; Shafer KM; Braff DL Biol Psychiatry; 2005 Jun; 57(12):1504-9. PubMed ID: 15953486 [TBL] [Abstract][Full Text] [Related]
35. Sensory gating and source analysis of the auditory P50 in low and high suppressors. Knott V; Millar A; Fisher D Neuroimage; 2009 Feb; 44(3):992-1000. PubMed ID: 19007892 [TBL] [Abstract][Full Text] [Related]
36. Impaired P50 suppression in fear extinction in obsessive-compulsive disorder. Nanbu M; Kurayama T; Nakazawa K; Matsuzawa D; Komiya Z; Haraguchi T; Ogura H; Hashimoto T; Yoshida S; Iyo M; Shimizu E Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):317-22. PubMed ID: 20035817 [TBL] [Abstract][Full Text] [Related]
37. Auditory sensory gating deficit and cortical thickness in schizophrenia. Thoma RJ; Hanlon FM; Sanchez N; Weisend MP; Huang M; Jones A; Miller GA; Canive JM Neurol Clin Neurophysiol; 2004 Nov; 2004():62. PubMed ID: 16012689 [TBL] [Abstract][Full Text] [Related]
38. Chronic effects of cannabis on sensory gating. Broyd SJ; Greenwood LM; Croft RJ; Dalecki A; Todd J; Michie PT; Johnstone SJ; Solowij N Int J Psychophysiol; 2013 Sep; 89(3):381-9. PubMed ID: 23628289 [TBL] [Abstract][Full Text] [Related]
39. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470 [TBL] [Abstract][Full Text] [Related]
40. Contribution of different EEG frequencies to auditory evoked potential abnormalities in schizophrenia. Jansen BH; Hegde A; Boutros NN Clin Neurophysiol; 2004 Mar; 115(3):523-33. PubMed ID: 15036047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]